Protective effect of aminophylline on renal perfusion changes induced by high-energy shockwaves identified by Gd-DTPA-enhanced first-pass perfusion MRI

Journal of Endourology

Volumn 14, Issue 2, 2000, Pages 117-121

  Chan, Andrew J ^a   Prasad, Pottumarthi V ^a   Priatna, Agus ^a   Mostafavai, Mohammad R ^a   Sunduram, Chandru ^a   Saltzman, Brian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG EFFECT; EXTRACORPOREAL LITHOTRIPSY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; UROLITHIASIS;

EID: 0034077906     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2000.14.117     Document Type: Article

References (20)

1. Chaussy C, Schneidt E, Jocham D. First clinical experiences with extracorporeally induced destruction of kidney stones by shock waves. J Urol 1982;127:417.
2. Evan AD, Willis LR, Connors BA, Reed G, McAteer JA, Lingeman JE. Shock wave lithotripsy induced renal injury. Am J Kidney Dis 1991;17:445.
3. Rubin JI, Arger PH, Pollack HM. Kidney changes after extracorporeal shock wave lithotripsy: CT evaluation. Radiology 1987;162:21.
4. Recker F, Ruebber H, Neuerburg J, Bex A, Deutz FJ, Hofstaeder F. Magnetic resonance imaging of acute and long-term alterations following extracorporeal shock wave lithotripsy in rats. Urol Int 1990;45:28.
5. Hasagawa S, Kato K, Takashi M, Zhju Y, Obata K, Miyake K. S100ao protein as a marker for tissue damage related to extracorporeal shock wave lithotripsy. Eur Urol 1993;24:393.
6. Wilbert DM, Strohmaier SL, Fluchter SH, Bichler K-H. Urinary proteins as parameters of renal functional changes after extracorporeal shock wave lithotripsy. Invest Urol 1989;3:249.
7. Gilbert BR, Riehle RR, Vaughan ED Jr. Extracorporeal shock wave lithotripsy and its effect on renal function. J Urol 1988;139:482.
8. Willis R, Evan AP, Connors BA, Reed G, Fineberg NS, Lingeman JA. Effects of extracorporeal shock wave lithotripsy to one kidney on bilateral glomerular filtration rate and PAH clearance in minipigs. J Urol 1996;156:1502.
9. Mostafavi MR, Chavez DR, Cannillo J, Saltzman B, Prasad PV. Redistribution of renal blood flow after SWL evaluated by Gd-DTPA-enhanced magnetic resonance imaging. J Endourol 1998;12:9.
10. Epstein FH, Rosen S, Galick-Piskorska G, Spokes K, Brezis M, Suva P. Relation of adenosine to medullary injury in the perfused rat kidney. Miner Electrolyte Metab 1990;16:185.
11. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994;45:1425.
12. Bidani AK, Churchill PC. Aminophylline ameliorates glycerol-induced acute renal failure in rats. Can J Physiol Pharmacol 1983;61:567.
13. Garrison RN, Wilson MA, Matheson PJ, Spain DA. Nitric oxide mediates redistribution of intrarenal blood flow during bacteremia. J Trauma 1995;39:90.
14. Prasad PV, Edelman RR, Buxton RB. Magnetic resonance perfusion imaging. Int J Imaging Syst Technol 1995;6:230.
15. Arend CJ, Bakris GL, Burrett JC, Megerian C, Spielman WS. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987;110:406.
16. Dinour D, Brezis M. Effects of adenosine on intrarenal oxygenation. Am J Physiol 1991;261:F787.
17. Osswald H, Muhlbauer B, Shenk F. Adenosine mediates tubuloglomerular feedback response: An element of metabolic control of kidney function. Kidney Int 1991;39:S128.
18. Lin JJ, Churchill PC, Bidani AK. Theophylline in rats during maintenance phase of post-ischemic acute renal failure. Kidney Int 1988;33:24.
19. Gouyon JB, Guignard JP. Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 1988;33:1078.
20. Prasad PV, Canillo J, Chavez DR, Pinchasin ES, Dolan RP, Walovitch R, Edelman RR. First pass perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol (in press).